🚨New paper!🚨 Introducing the General Change Mechanisms Questionnaire (GCMQ) - a psychometric tool to measure psychotherapeutic processes related to psychedelic experiences A privilege to work w/this amazing team #openaccess in J of #Psychopharmacology journals.sagepub.com/doi/10.1177/02…

Moving to something less controversial than MDMA for a minute - *consciousness*! Join us in Tuscany, Italy Jan 26-31, 2025 for a Gordon Research Conference on Consciousness, Anesthesia & Evolutionary Biology. Incredible speaker lineup. grc.org/consciousness-…

Know someone with back pain? We're recruiting for a study of #psilocybin for chronic low back pain! screen: stanforduniversity.qualtrics.com/jfe/form/SV_da… Please RT ........................................... Close collab w TrPR Program @ UCSF Josh Woolley MD/PhD Michael Silver Berkeley Neuroscience #ChronicPain

This is the early beginning of the kind of trials we need in order to move MDMA-assisted psychotherapy for PTSD forward. maps.org/2024/08/27/map…

Ed Marcantonio Niccolò Terrando Jeff Browndyke Michael Devinney Heather Whitson I'll miss many folks Duke University but my fam & I are looking forward 2 returning 2 & living in N. California & the many great friends & colleagues I'll be joining Stanford Anesthesiology Boris D Heifets Vivianne Tawfik, MD, PhD GaudilliereLab Stanford Neurosurgery Stanford Neurology & Neurological Sciences & Stanford Neuroanesthesiology (6/x)

Welcome to Stanford Miles Berger!

🚨🍾Our paper on psychedelic-like experiences in breathwork was published today in Cerebral Cortex🍾🚨 Fast-paced breathwork can induce conscious contents and neural dynamics ~similar~ to psychedelics🍄 t.ly/TIDJo w/ Enzo Tagliazucchi, Andres Canales-Johnson, and Tristan Bekinschtein 🧵

This is a glimpse of the future; take note. "The patient consumed 2 grams, 5.5 grams, and then 3.5 grams of psilocybe cubensis mushrooms. The second dose was three days after the first, and the third was two days later. Alongside dosing sessions, the patient partook in

Quick thread on our JAMA psych paper: multiple studies, often in large samples, report either positive or negative associations between cognition and mental health. What do you notice about the effect in this gif, where quartiles of mental health symptoms are separately plotted?

Thanks for the highlight The Scientist! Protecting preexisting myelin and promoting oligodendrogensis in disease states are going to require distinct therapeutic strategies! #MultipleSclerosis #neuroscience #Microscopy #aging #Biology #Alzheimers the-scientist.com/older-oligoden…

Who are your favorite academic researchers / public institutions with ongoing psychedelic research? I'm making a list and don't want to miss anyone!

Absolutely love this idea. How did psychedelic therapeutic experiences get so stuck between the ears?

In the 1970s, the FDA rejected psychedelic-assisted therapy. This was followed by revelations about MK Ultra, and hippy utopianism turned into paranoia. I have a sense the psychedelic renaissance might be in a similar historical moment. ecstaticintegration.org/p/the-paranoid…

Robin Carhart-Harris Isn’t it just that the shoe is on the other foot now?

Sense prevails in some quarters… Ketamine is a psychedelic. psychiatryonline.org/doi/10.1176/ap…

“Ketamine’s place within the psychoactive pharmacopeia is perpetually controversial, perhaps because it exposes the fault lines in a premise of modern psychopharmacology, namely, that a drug response…occurs through the action at individual receptors.” psychiatryonline.org/doi/10.1176/ap…

Episode 2 is live wherever you get your pods! Alaina gives a brief history of the language around #psychedelics, followed by a very interesting discussion with Boris D Heifets on the various aspects of the psychedelic experience, #pharmacology and more! open.spotify.com/episode/57ebGr…

Episode 2!! What the heck is a psychedelic?? Tune in on our website for free, subscribe on Apple, Spotify or wherever else you get your podcasts! #psychedelic #psychedelicscience #yourbrainonscience psychedelicbrainscience.com/podcast/episod…

Chronic low back pain affects both body & mind. 1 in 5 people with this pain experience sadness, fear, & anxiety. Scientists are exploring a whole-person care approach combining antidepressants with physical therapy to treat pain & mood. go.nih.gov/2YxXR14 #NIHPainProgress